012 — Nashville, Tennessee

012 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

012 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor.

Sponsors: MediLink Therapeutics (Suzhou) Co., Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 012?

012 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 012 conducted?

012 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor.

Is 012 accredited by Crixeo Health?

012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.